DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket
seekingalpha
2024/02/05
DMK Pharmaceuticals (NASDAQ:DMK) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2.
DMK -20.90% premarket to $0.4113
Source: Press Release
More on DMK Pharmaceuticals
Seeking Alpha’s Quant Rating on DMK Pharmaceuticals